[1]
Khan, A. et al. 2026. Taletrectinib: Transforming Outcomes in ROS1-Positive Non- Small Cell Lung Cancer. Asian Pacific Journal of Cancer Nursing. (Oct. 2026), 20261021. DOI:https://doi.org/10.31557/APJCN.2208.20261021.